Transparency Market Research: Anti-radiation Drugs Market to Reach US$ 9.6 Bn by 2031, TMR Study
Rise in investment in R&D by pharma and biotech companies for the development of effective drugs for acute radiation syndrome or ARS propels market growthIncrease in efforts by pharmaceutical